IFN-γ-Preconditioned Human Gingival-Derived Mesenchymal Stromal Cells Inhibit Plasmacytoid Dendritic Cells via Adenosine
Authors:
- William de Jesús Ríos-RíosWRWilliam de Jesús Ríos-Ríos
- Sorely Adelina Sosa-LuisSSSorely Adelina Sosa-Luis
- Alexia Almaraz-ArreortuaAAAlexia Almaraz-Arreortua
- Patricia Vargas-BenitezPVPatricia Vargas-Benitez
- Héctor Ulises Bernardino-HernándezHBHéctor Ulises Bernardino-Hernández
- Jaime Vargas-ArzolaJVJaime Vargas-Arzola
- Luis Alberto Hernández-OsorioLHLuis Alberto Hernández-Osorio
- María de Los Ángeles Romero-TlaloliniMRMaría de Los Ángeles Romero-Tlalolini
- Sergio Roberto Aguilar-RuizSASergio Roberto Aguilar-Ruiz
- Honorio Torres-AguilarHTHonorio Torres-Aguilar
Open Access
- 4 June 2024
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 14 (6) , 658
Abstract
Plasmacytoid dendritic cells (pDCs) are vital players in antiviral immune responses because of their high levels of IFN-α secretion. However, this attribute has also implicated them as critical factors behind the immunopathogenesis of inflammatory diseases, and no currently available therapy can efficiently inhibit pDCs’ aberrant activation. Mesenchymal stromal cells (MSCs) possess stromal immunomodulatory functionality, regulating immune cell activation through several mechanisms, including the adenosinergic (CD39/CD73/adenosine) pathway. The IFN-γ preconditioning of bone marrow MSCs improves their inhibitory properties for therapy applications; however, isolating human gingival tissue-derived MSCs (hGMSCs) is more accessible. These cells have shown better immunomodulatory effects, yet the outcome of IFN-γ preconditioning and its impact on the adenosinergic pathway has not been evaluated. This study first validated the immunoregulatory properties of primary-cultured hGMSCs, and the results showed that IFN-γ preconditioning strengthens CD39/CD73 coexpression, adenosine production, and the regulatory properties of hGMSC, which were confirmed by describing for the first time their ability to reduce pDC activation and their IFN-α secretion and to increase the frequency of CD73+ pDC. In addition, when CD73′s enzymatic activity was neutralized in hGMSCs, adenosine production and the IFN-γ preconditioning effect were restrained. This evidence might be applied to design hGMSCs- and adenosine-based immunotherapeutic strategies for treating inflammatory disorders that are associated with pDC overactivation.Keywords
Funding Information
- CONACyT (#285480)
- Department of Basic and Clinical Immunology Research of the Biochemical Sciences Faculty, Universidad Autónoma’ Benito Juárez’ de Oaxaca (#285480)
This publication has 38 references indexed in Scilit:
- Human plasmacytoid dendritic cells express the functional purinergic halo (CD39/CD73)Purinergic Signalling, 2023
- Plasmacytoid dendritic cells promote the pathogenesis of Sjögren's syndromeBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2021
- The adenosinergic pathway in mesenchymal stem cell fate and functionsMedicinal Research Reviews, 2021
- Plasmacytoid dendritic cell biology and its role in immune‐mediated diseasesClinical & Translational Immunology, 2020
- Adenosine signaling and the immune system: When a lot could be too muchImmunology Letters, 2019
- Interactions between mesenchymal stem cells and the immune systemCellular and Molecular Life Sciences, 2017
- Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cellsStem Cells, 2016
- MSCs inhibit bone marrow-derived DC maturation and function through the release of TSG-6Biochemical and Biophysical Research Communications, 2014
- Regulation of TLR7/9 signaling in plasmacytoid dendritic cellsProtein & Cell, 2012
- Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicineBiochemical and Biophysical Research Communications, 2010